Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest Peter ShamamianMarie ManciniSuzanne L. Topalian Original Articles Pages: 73 - 83
Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs Stuart C. HelfandSteve A. SoergelPaul M. Sondel Original Articles Pages: 84 - 92
Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells Wolfgang HerrThomas WölfelAlexander Knuth Original Articles Pages: 93 - 99
Effect of interferon γ and tumour necrosis factor α on sensitivity to cisplatin in ovarian carcinoma cell lines Sean ClarkMichael A. McGuckinBruce G. Ward Original Articles Pages: 100 - 104
Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide Michael L. SalgallerJeffrey S. WeberSteven A. Rosenberg Original Articles Pages: 105 - 116
Low-dose melphalan-induced shift in the production of a Th2-type cytokine to a Th1-type cytokine in mice bearing a large MOPC-315 tumor Leonid GorelikAnna ProkhorovaMargalit B. Mokyr Original Articles Pages: 117 - 126
ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon γ production in interleukin-2-activated T cells Anita S. -F. ChongXingLi JiangLloyd H. Graf Jr. Original Articles Pages: 127 - 134
Reduction in the toxicity of aminopterin—monoclonal-antibody conjugates by leucovorin A. J. RowlandG. A. Pietersz Original Articles Pages: 135 - 139